ClinicalTrials.Veeva

Menu

Feasibility Study of Laparoendoscopic Single Site Surgical Staging for Endometrial Cancer (LESS-E)

A

Asan Medical Center

Status

Completed

Conditions

Endometrial Cancer

Treatments

Procedure: Four-port laparoscopic surgical staging
Procedure: single-port laparoscopic surgical staging

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To compare the feasibility, safety, and efficacy between single-port and four-port laparoscopic surgical staging in patients with early stage endometrial cancer.

Enrollment

107 patients

Sex

Female

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Previously untreated, histologically confirmed endometrial cancer

  • Presumed FIGO stage 1

  • Endometrioid adenocarcinoma

  • patient who is planned to undergo surgical staging

  • adequate oran function

    1. WBC > 3000 cells/mcl
    2. Platelets > 100000/mcl
    3. Creatinine < 2.0 mg/dL
    4. Bilirubin < 1.5 * normal and SGOT or SGPT < 3 * normal
  • American Society of Anesthesiologists Physical Status I-II

  • Eastern Cooperative Oncology Group performance status 0-2

  • Patients who have signed an approved Informed Consent

Exclusion criteria

  • Uncontrolled medical disease
  • Active infectious disease requiring antibiotics
  • Previous pelvic radiation therapy
  • Pregnant and lactating woman
  • Patient who requires additional surgical procedures which are not necessary for surgical staging of endometrial cancer

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

107 participants in 2 patient groups

Single-port surgery group
Experimental group
Description:
Single-port laparoscopic surgical staging including total hysterectomy, pelvic lymph node dissection, and/or bilateral salpingooophorectomy, and/or para-aortic lymph node dissection
Treatment:
Procedure: single-port laparoscopic surgical staging
Four-port surgery group
Active Comparator group
Description:
Four-port laparoscopic surgical staging including total hysterectomy, pelvic lymph node dissection, and/or bilateral salpingooophorectomy, and/or para-aortic lymph node dissection
Treatment:
Procedure: Four-port laparoscopic surgical staging

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems